Government in the Sunshine Act Meeting Notice, 16509 [2010-7403]

Download as PDF Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Notices treatment unless the information has already been granted such treatment during the proceedings. All such requests should be directed to the Secretary of the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is sought will be treated accordingly. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in section 210.42–43 of the Commission’s Rules of Practice and Procedure (19 CFR 210.42–43). BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION AGENCY: United States International Trade Commission. ACTION: Scheduling of the final phase of countervailing duty and antidumping investigations. BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [USITC SE–10–005] Government in the Sunshine Act Meeting Notice mstockstill on DSKH9S0YB1PROD with NOTICES [FR Doc. 2010–7403 Filed 3–30–10; 11:15 am] Certain Potassium Phosphate Salts From China [FR Doc. 2010–7279 Filed 3–31–10; 8:45 am] AGENCY HOLDING THE MEETING: United States International Trade Commission. TIME AND DATE: March 31, 2010 at 11 a.m. PLACE: Room 101, 500 E Street, SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agenda for future meetings: none. 2. Minutes. 3. Ratification List. 4. Inv. No. 731–TA–1059 (Review) (Hand Trucks and Certain Parts Thereof from China)—briefing and vote. (The Commission is currently scheduled to transmit its determination and Commissioners’ opinions to the Secretary of Commerce on or before April 15, 2010.) 5. Outstanding action jackets: (1) Document No. GC–10–028 concerning Inv. No. 337–TA–644 (Certain Composite Wear Components and Products Containing Same). (2) Document No. GC–10–031 concerning Inv. No. 337–TA–568 (Certain Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoietin). (3) Document No. GC–10–034 concerning Inv. No. 337–TA–668 16:51 Mar 31, 2010 By order of the Commission. Issued: March 29, 2010. William R. Bishop, Hearings and Meetings Coordinator. [Investigations Nos. 701–TA–473 (Final) and 731–TA–1173 (Final)] By order of the Commission. Issued: March 25, 2010. Marilyn R. Abbott, Secretary to the Commission. VerDate Nov<24>2008 (Certain Non-Shellfish Derived Glucosamine and Products Containing Same). In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. Earlier notification of this meeting was not possible. Jkt 220001 SUMMARY: The Commission hereby gives notice of the scheduling of the final phase of countervailing duty investigation No. 701–TA–473 (Final) under section 705(b) of the Tariff Act of 1930 (19 U.S.C. 1671d(b)) (the Act) and the final phase of antidumping investigation No. 731–TA–1173 (Final) under section 735(b) of the Act (19 U.S.C. 1673d(b)) to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of subsidized and less-than-fair-value imports from China of certain potassium phosphate salts, provided for in subheadings 2835.24.00 and 2835.39.10 of the Harmonized Tariff Schedule of the United States.1 For further information concerning the conduct of this phase of the investigations, hearing procedures, and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A through 1 For purposes of these investigations, the Department of Commerce has defined the subject merchandise as anhydrous Monopotassium Phosphate (MKP), anhydrous Dipotassium Phosphate (DKP) and Tetrapotassium Pyrophosphate (TKPP), whether anhydrous or in solution (collectively ‘‘phosphate salts’’). Certain Potassium Phosphate Salts from the People’s Republic of China: Preliminary Determination of Sales at Less Than Fair Value, 75 FR 12508, March 16, 2010. PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 16509 E (19 CFR part 201), and part 207, subparts A and C (19 CFR part 207). DATES: Effective Date: March 16, 2010. FOR FURTHER INFORMATION CONTACT: Angela M. W. Newell (202–708–5409), Office of Investigations, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at http://edis.usitc.gov. SUPPLEMENTARY INFORMATION: Background.—The final phase of these investigations is being scheduled as a result of affirmative preliminary determinations by the Department of Commerce that certain benefits which constitute subsidies within the meaning of section 703 of the Act (19 U.S.C. 1671b) are being provided to manufacturers, producers, or exporters in China of certain potassium phosphate salts, and that such products are being sold in the United States at less than fair value within the meaning of section 733 of the Act (19 U.S.C. 1673b). The investigations were requested in a petition filed on September 29, 2009, by ICL Performance Products, LP, St. Louis, MO and Prayon, Inc. Augusta, GA. Participation in the investigations and public service list.—Persons, including industrial users of the subject merchandise and, if the merchandise is sold at the retail level, representative consumer organizations, wishing to participate in the final phase of these investigations as parties must file an entry of appearance with the Secretary to the Commission, as provided in section 201.11 of the Commission’s rules, no later than 21 days prior to the hearing date specified in this notice. A party that filed a notice of appearance during the preliminary phase of the investigations need not file an additional notice of appearance during this final phase. The Secretary will maintain a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigations. Limited disclosure of business proprietary information (BPI) under an administrative protective order (APO) and BPI service list.—Pursuant to E:\FR\FM\01APN1.SGM 01APN1

Agencies

[Federal Register Volume 75, Number 62 (Thursday, April 1, 2010)]
[Notices]
[Page 16509]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7403]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-10-005]


Government in the Sunshine Act Meeting Notice

Agency Holding the Meeting: United States International Trade 
Commission.

Time and Date: March 31, 2010 at 11 a.m.

Place: Room 101, 500 E Street, SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

Status: Open to the public.

Matters to be Considered:
    1. Agenda for future meetings: none.
    2. Minutes.
    3. Ratification List.
    4. Inv. No. 731-TA-1059 (Review) (Hand Trucks and Certain Parts 
Thereof from China)--briefing and vote. (The Commission is currently 
scheduled to transmit its determination and Commissioners' opinions to 
the Secretary of Commerce on or before April 15, 2010.)
    5. Outstanding action jackets:
    (1) Document No. GC-10-028 concerning Inv. No. 337-TA-644 (Certain 
Composite Wear Components and Products Containing Same).
    (2) Document No. GC-10-031 concerning Inv. No. 337-TA-568 (Certain 
Products and Pharmaceutical Compositions Containing Recombinant Human 
Erythropoietin).
    (3) Document No. GC-10-034 concerning Inv. No. 337-TA-668 (Certain 
Non-Shellfish Derived Glucosamine and Products Containing Same).
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting. Earlier notification of this meeting 
was not possible.

    By order of the Commission.

    Issued: March 29, 2010.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. 2010-7403 Filed 3-30-10; 11:15 am]
BILLING CODE 7020-02-P